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Abstract
Background:  Over the past five years in situ hybridization techniques employing tyramide
amplification reagents have been developed and promise the potential detection of low/single-copy
nucleic acid sequences. However the increased sensitivity that tyramide amplification brings about
may also lead to problems of background staining that confound data interpretation.
Methods: In this study those factors enabling background-free biotinyl-tyramide based in situ
hybridization assay of formalin-fixed paraffin-embedded tissues have been examined. SiHa, HeLa
and CaSki cell lines known to contain HPV integrated into the cell genome, and archival cervical
pre-invasive lesions and carcinomas have been successfully assessed using biotinylated HPV and
centromeric probes.
Results: The single most important factor both for sensitivity and clean background was a tissue
unmasking regimen that included treatment with 10 mM sodium citrate pH 6.0 at 95°C followed
by digestion with pepsin/0.2 M HCl. Concentrations both of probe and primary streptavidin-
peroxidase conjugate and pH of hybridization mix and stringency washes were also critical for
sensitivity. Certain probes were more associated with background staining than others. This
problem was not related to probe purity or size. In these instances composition of hybridization
mix solution was especially critical to avoid background. 3-amino-9-ethylcarbazole was preferred
over 3,3'-diaminobenzidene as a chromogen because background was cleaner and the 1–2 copies
of HPV16 integrated in SiHa cells were readily demonstrable. HPV detection on metaphase spreads
prepared from SiHa cells was only successful when a fluorescent detection method was combined
with tyramide reagent. 'Punctate' and 'diffuse' signal patterns were identified amongst tissues
consistent with the former representing integration and 'diffuse' representing episomal HPV. Only
punctate signals were detected amongst the cell lines and were common amongst high-grade pre-
invasive lesions and carcinomas. However it remains to be determined why single/low-copy
episomal HPV in basal/parabasal cells of low-grade lesions is not also detectable using tyramide-
based techniques and whether every punctate signal represents integration.
Conclusions:  A tyramide-based in situ hybridization methodology has been established that
enables sensitive, background-free assay of clinical specimens. As punctate signals characterize HPV
in high-grade cervical lesions the method may have potential for clinical applications.
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Background
Over the past five years, in situ hybridization techniques
employing tyramide amplification reagents have been
developed and promise the potential detection of low/
single-copy nucleic acid sequences. However the
increased sensitivity that tyramide amplification brings
about may also lead to problems of background staining
that confound data interpretation. In this study factors
that allow reproducible, sensitive, and clean biotinyl-tyra-
mide based in situ hybridization assay have been investi-
gated. Formalin-fixed paraffin-embedded (FFPE) human
papillomavirus (HPV) positive cell-lines (SiHa, HeLa and
CaSki,) as well as FFPE cervical lesions (pre-invasive and
invasive) infected with HPV have been used as model sys-
tems. In addition metaphase chromosome spreads pre-
pared from SiHa cells have been examined.
Materials
Cell Lines
SiHa cells which contain 1–2 copies of HPV 16 integrated
at chromosome 13q21-31, HeLa cells which contain up to
50 copies of HPV 18 integrated at 5 sites and CaSki cells
which contain up to 600 copies of HPV 16 integrated at
multiple sites [1] were obtained from the ATCC, Manas-
sas, VA. After culture, cells were fixed with 4% paraformal-
dehyde/PBS and then suspended in 2% agar in normal
saline. The plug of fixed cells was then paraffin-embedded
by routine processing. Slides of paraffin-embedded SiHa
cells were also supplied with the GenPoint tyramide rea-
gent kit (DAKO, Carpinteria, CA).
Cervical Lesions
A selection of formalin-fixed, paraffin-embedded (FFPE)
cervical lesions was collected from the Department of
Pathology archives, observing Institution Review Board
guidelines. HPV type was determined using a modifica-
tion of GP5+/6+ PCR assay [2].
Probes
Full-length (~8 kb) HPV type specific sequences contained
in plasmid vectors were obtained. HPV types 11 and 16
were received courtesy of Dr E-M de Villiers Deutsches
Krebsforschungszentrum (DKFZ), Heidelberg, Germany
[3,4]. HPV type 33 DNA was received from Dr G Orth,
Institut Pasteur, Paris, France [5]. HPV types 6, 18, 31, 35,
43 and 56 were obtained from the American Type Culture
Collection (ATCC, http://www.atcc.org/Home.cfm)
[ATCC catalog numbers: 45150 (HPV 6); 45152 (HPV
18); 65446 (HPV 31); 40330 and 40331 (HPV-35); 40338
and 40339 (HPV 43); 40549 (HPV 56)]. Human chromo-
some DNA specific to alpha-satellite centromeric regions
was also obtained from the ATCC [catalog numbers:
61078 (D9Z3, chromosome 9); 61396 (D10S71, chromo-
some 10); 65438 (D11Z1 chromosome 11); 61398
(D12Z1, chromosome 12) and 65442 (D17Z1, chromo-
some 17). Plasmid/insert DNA sequences were isolated
from bacterial cultures by column purification (Qiagen,
Valencia, CA) and were biotin-labeled by nick-translation
(Invitrogen, Carlsbad, CA).
Methods and Results
In situ hybridization can be divided into five phases: sec-
tion preparation, tissue unmasking, hybridization, post-
hybridization washes, and, detection. For each of these
phases there are multiple potential variables that could
affect sensitivity and background staining. The effects of a
variety of these factors on sensitivity and background have
been examined for each phase. Clearly, when there are so
many potential variables, it is not practicable to test each
variable relative to every other. The factors strictly control-
led as variables are indicated in the description for each
phase. Experimental regimens were tested on cell lines
and a minimum of 3 up to 24 tissue sections from 1 to 8
patients. The HPV-type present in a particular lesion was
determined by GP5+/6+ assay [2] and in situ hybridiza-
tion was then performed using the appropriate HPV plas-
mid probe. If the specific HPV-type probe was not
available wide-spectrum probe 1a (DAKO) was used.
Section Preparation and Dewaxation
Six-micrometer thick sections were floated onto slides
using autoclaved distilled water in the preparation bath.
ADCELL™ slides (Erie Scientific Company, Portsmouth,
NH) were found to provide excellent retention of tissues
during NISH processing and were marginally better than
'home' prepared silane coated slides in terms of non-spe-
cific staining of glass. Sections were baked onto slides
overnight at 55°C. Sections were dewaxed with xylene,
washed with 100% ethanol, 90% ethanol and 75% etha-
nol and rehydrated with sterile distilled water.
Tissue Unmasking
Non-Protease Unmasking
Five regimens were tested: no pretreatment; 10 mM
sodium citrate pH6.0, 90–95°C 30–40 minutes, with and
without the addition of 0.1% Triton; 100 mM Tris-HCl
pH 6.0 – pH 10.0, 80 – 95°C 15 – 40 minutes; 1 M
sodium thiocyanate 80°C 10 minutes. After dewaxation
and air-drying, slides were immersed in these solutions in
Coplin jars pre-heated to temperature in water baths. After
incubation, Coplin jars were removed from the water bath
and slides immersed in sodium citrate or Tris-HCl and
were allowed to sit in solution for a further 20 minutes
before being rinsed with water and air-dried. Non-inclu-
sion of one of these steps predisposed to background
staining. Cleanest results were obtained with a sodium cit-
rate step. There was no benefit to sensitivity of back-
ground by inclusion of Triton, which tended to result in
loss of tissue from slides. Several other pre-treatments reg-
imens were not tested. These include the use of 1 mMBMC Clinical Pathology 2003, 3 http://www.biomedcentral.com/1472-6890/3/2
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EDTA pH8.0 at high-temperature, and 'tissue unmasking'
solutions available from BioGenex, DAKO, Zymed and
other companies.
Protease Unmasking
Protease digestion was essential to enable target signal
detection with any of the above unmasking aids. Three
proteases were tested: pepsin/0.2 M HCl, proteinase K /
PBS and protease VIII / PBS. Pepsin/0.2 M HCl digest pre-
ceded by sodium citrate treatment yielded the cleanest
and most sensitive detection of viral and chromosomal
sequences. The pepsin solution was prepared by heating
50 mls of 0.2 M HCl to 37°C and then mixing in 100 mg
of pepsin (Sigma P-7012, Sigma, St Louis, MO). Pepsin
was allowed to dissolve for 20 minutes then 2 ml was
mixed with 38 ml 0.2 M HCl at room temperature (25°C)
to yield a 100µg/ml solution. Slides were incubated with
this solution at 25°C for 2 minutes (fixed cell lines) up to
35 minutes (CIN) lesions. The majority of FFPE pathology
specimens required 15 minutes digestion. Slides were
then rinsed with water, washed in three changes of PBS/
0.05% Tween 20 for a total of 15 minutes and then rinsed
in water. Tissues were then immersed in methanol/0.6%
hydrogen peroxide for 30 minutes as a precaution against
endogenous peroxidase followed by water rinses for 15
minutes and were then air-dried. The three proteases were
tested in the absence of non-protease unmasking steps.
Pepsin and proteinase K were tested with all four non-pro-
tease unmasking steps and protease VIII was only tested in
combination with sodium citrate unmasking. Overall tis-
sue unmasking was found to be one of the most critical
steps for sensitive detection.
Post-digestion fixation
Including post-digestion fixation steps with 4% parafor-
maldehyde or methanol/acetic acid (4:1) in the NISH
assay were investigated when pepsin or proteinase K were
used with or without sodium citrate. No benefits to sensi-
tivity or background cleanliness were identified.
Hybridization
Hybridization Mix Components
Dextran Sulfate (Sigma) was tested at concentrations rang-
ing from 0% to 20%, and formamide (Sigma) at concen-
trations ranging from 20% to 60% (using pepsin with or
without sodium citrate unmasking regimen). Other pro-
teases used were tested with 10% dextran sulphate, 50%
formamide. The following buffer solutions were tested:
2X SSC (300 mM NaCl, 30 mM sodium citrate), 2X SSPE
(300 mM NaCl, 20 mM NaH2PO4, 2 mM EDTA), and, 2X
STE (300 mM NaCl, 50 mM Tris-HCl, 2 mM EDTA). Solu-
tions were tested at pH 6.0, 6.5, 7.0, 7.5, and 8.0 using a
pepsin/sodium citrate regimen. Otherwise the proteases
used (with or without tissue pretreatment) were tested
only with 2X SSC pH7.0. Sonicated human placental
DNA (Sigma D3287) at a concentration of 400 ng/µl
hybridization mix was included when using an HPV
probe. Sonicated salmon sperm DNA (Sigma) at the same
concentration was included when human sequence cen-
tromeric probes were used. A commercially available
hybridization mix (DAKO S3305) was also assessed.
HPV or centromeric plasmid was labeled with biotin by
nick-translation (Invitrogen Life Technologies, Carlsbad,
CA). Nick-translation reactions were allowed to progress
for different lengths of time to enable the effect of probe
size to be examined. Size of heat denatured (i.e. single
strand) probe fragments was checked by agarose gel elec-
trophoresis of denatured probe followed by Southern
transfer and demonstration of biotin by BluGene kit (Inv-
itrogen Life Technologies). Probes were purified through
mini-columns (Qiagen) and tested at concentrations
ranging from 0.1 up to 2 ng/µl hybridization mix. This
assessment was performed for tissues treated according to
the protocol listed in Table 1.
Table 1: Summary of Optimized Protocol for FFPE Tissues
1. Cut sections onto ADCELL™ coated slides using molecular biology grade water.
2. Dewax and treat with 10 mM sodium citrate pH6.0 at 95°C.
3. Digest with 100µg/ml pepsin/0.2 M HCL at room temperature.
4. Treat slides with 0.6%H2O2/methanol.
5. Apply probe/hybridization mix (pH7.0) to section, seal under coverslip, heat denature at 95°C.
6. Hybridize overnight at 37°C.
7. Remove coverslip under 2X SSC/0.05% Tween20 pH7.0 at room temperature.
8. Wash slides in 0.2X SSC/0.05% Tween20 pH7.0 at 55°C.
9. Apply primary streptavidin-peroxidase conjugate (DAKO) diluted 1:500 (HPV) or 1:5000 (centromeric probes).
10. Apply biotinyl-tyramide and secondary streptavidin peroxidase (DAKO).
11. Demonstrate hybridization signal with 3-amino-9-ethylcarbazole (AEC) applied for ~10 minutes.BMC Clinical Pathology 2003, 3 http://www.biomedcentral.com/1472-6890/3/2
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Absence of dextran sulfate resulted in background prob-
lems and at a concentration of 20% sensitivity was signif-
icantly reduced. The tested range of formamide
concentrations had little effect on background staining.
Hybridization mixes prepared with STE invariably gave
background problems. There was little difference between
SSC and SSPE buffers. Hybridization mix pH was found to
be important. Sensitivity was significantly reduced at pH
< 7.0. Background was significantly increased at pH > 7.5.
It was noted that the pH of a 2X SSC solution diluted from
20X SSC pH 7.0 had a pH of ~7.8 and that it was prefera-
ble to adjust pH hybridization mix (buffer, formamide,
dextran sulfate) directly. Probes nick-translated to yield
denatured fragments primarily ranging in size from 500
bases to 100 bases yielded strongest and cleanest signals.
Sensitivity was significantly lowered when single-strand
probe fragment size was predominantly below < 200
bases in length. Probe concentration was important for
sensitivity, which dropped noticeably when the concen-
tration was below 0.5 ng/µl. It was not possible to com-
pensate for loss in sensitivity by subsequently increasing
the concentration of detection reagents. To detect the 1–2
copies of HPV 16 in SiHa cells HPV probe at a concentra-
tion of 1 ng/µl was sufficient. Centromeric probes were
used at 0.5 ng/µl concentration.
"Dirty Probes"
Background-free results were obtained for all centromeric
probes tested and most HPV type probes tested. However
certain HPV probes such as that for type 31 were consist-
ently associated with non-specific background staining.
This problem remained despite repeat preparation of plas-
mid by column extraction (Qiagen), repeat nick-transla-
tion of probe to yield different sized fragments, and repeat
purifications of labeled probe through mini-columns
(Qiagen) or by isopropanol precipitation. This suggests
the staining is somehow related to the physical properties
of the probe sequence structure and is not due to some
unidentified contaminant. However this non-specific
staining was virtually eliminated when the commercially
supplied hybridization mix (DAKO) was used together
with pH controlled post-hybridization washes (see
below). A number of other hybridization mix additives
that may benefit sensitivity/background were not tested.
These include ficoll, polyvinylpyrolidone, bovine serum
albumin, (individually or together [i.e. Denhardt's rea-
gent]), sodium dodecyl sulfate, Tween 20 and Triton X-
100. Hybridization mix is also available from other com-
mercial companies such as BioGenex.
Denaturation
Hybridization mix was applied to sections and coverslips
were sealed with rubber cement. Slides were placed into
Terasaki plates containing 2 mls 5X SSC. The Terasaki
plates were then placed onto a 2 cm thick aluminum
block preheated in an oven set at 95°C. Terasaki plates
were removed after 17 minutes. This form of denaturation
was found to be marginally more effective than placing
slides directly onto the heated block for 5 minutes.
Hybridization temperature and time
Hybridization conditions and post-hybridization washes
determine ISH assay stringency, i.e. the number of
matched/mismatched sequences permitted between a
probe and its target. The melting temperature Tm is deter-
mined by a number of factors that include temperature,
monovalent cation concentration, formamide, pH, probe
fragment length, GC content and mismatched hybrids.
Herrington and colleagues have specifically examined Tm
as it applies to ISH and have defined the term "tissue Tm",
(Tm 
t ), having noted that the theoretical Tm (derived from
analysis of solution kinetics) did not match the empiri-
cally derived value for Tm in HPV ISH assays using full-
length probes, suggesting that hybridization involving tis-
sue sections involves additional determinants of Tm. After
several studies [6–8] it was concluded that the main differ-
ence between Tm and Tm 
t is (probably) due to the use of a
different end-point for measurement (e.g. a chromogenic
stain following application of intermediary reagents)
rather than biochemical alteration of DNA-DNA interac-
tions (measured by spectrophotometry) [8]. It was also
concluded that mismatched probe targets should be
removed using empirically derived post-hybridization
washing conditions in order to achieve specificity and that
appropriate conditions should be determined by experi-
ment rather than calculated theoretically from Tm. In a
later study Herrington et al. [9] examined the ability of
ISH to discriminate HPV types using full-length plasmid
probes. It was concluded that when using a high sensitiv-
ity system in which high-copy number infection is present
then ISH can lead to erroneous typing data. Accordingly,
HPV typing of lesions in the present study was determined
by PCR assay and hybridization/wash conditions were
then optimized empirically for sensitivity and clean back-
ground using the appropriate HPV-type probe as indi-
cated following the PCR. Hybridizations (that included
sonicated human placental DNA in the hybridization
mix) were tested at 42°C and 37°C for 2 hours or over-
night. Highest sensitivity and cleanest background was
obtained with overnight 37°C incubations followed by
high-stringency washes (see below).
Controls
Nick-translated biotin-labeled pUC18 plasmid was used
as a control for non-specific probe binding and HPV
probes were also applied to normal cervical tissues. It was
confirmed that a plasmid vector probe did not result in
hybridization signal with an HPV-positive lesion and that
HPV probe did not result in signal with normal tissue.BMC Clinical Pathology 2003, 3 http://www.biomedcentral.com/1472-6890/3/2
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Post-Hybridization Washes
SSC, SSPE and STE buffers at pH 6.0, 6.5, 7.0, 7.5 and 8.0
were tested as variables of the protocol listed in Table 1.
After pealing away rubber cement, slides were immersed
in 2X buffer/0.05% Tween 20 and coverslips were eased
off slides. Slides were then washed at stringency: 2X – 0.1X
buffer/0.05% Tween 20 at 37°C -55°C with or without
50% – 60% formamide.
As with hybridization mix, wash buffer pH was an impor-
tant factor for a clean result. Background tended to occur
at pH6.0 and at pH8.0. Sensitivity was reduced at < pH7.0.
STE buffer gave background problems possibly because
the pH of this buffer tended to decrease as temperature
increased whereas SSC and SSPE better retained pH. The
use or otherwise of formamide did not alter background-
staining status. HPV signal in SiHa cells remained detect-
able washing in up to 0.2X SSC/0.05% Tween 20 at 55°C.
Detection of Biotin
Biotin signal was demonstrated by serial application of
primary streptavidin-peroxidase, biotinyl-tyramide and
secondary streptavidin-peroxidase [GenPoint Catalyzed
Signal Amplification System] (DAKO). Primary streptavi-
din-peroxidase was tested at dilutions ranging from 1:250
to 1:15 000 in PBS/0.05% Tween 20. For the demonstra-
tion of HPV 16 in SiHa cells a 1:500 dilution applied for
30 minutes at room temperature was sufficient. Centro-
meric probes were very readily detectable. Dilutions of <
1:5000 were sufficient. Biotinyl-tyramide and secondary
streptavidin-peroxidase were applied according to kit
instructions. Tissues were washed with PBS/0.05% Tween
20 between incubations.
Chromogen
Peroxidase was demonstrated using either DAB [3,3'-
diaminobenzidene] (DAKO) or AEC [3-amino-9-ethylcar-
bazole] (Sigma). Use of AEC was of particular benefit in
avoiding non-specific background staining. In addition
the signal from AEC tended to be more discrete than that
from DAB. The 1–2 copies of HPV 16 in SiHa cells were
readily detectable using AEC, which was applied for 5 – 10
minutes. A more intense stain was obtained with DAB,
which was applied for 1–3 minutes. Tissues were counter-
stained with hematoxylin. 'Punctate' signals indicative of
integration (see discussion) were demonstrated with
CaSki, HeLa, SiHa, and carcinoma samples (Figure
1A,1B,1C,1D,1E,1F). 'Diffuse' signals (indicative of episo-
mal HPV), 'diffuse' and 'punctate', or 'punctate' signals
alone were demonstrated amongst pre-invasive lesion
samples (Figure 2A,2B and 2C). These lesions were delib-
erately over- or under-digested. There was no evidence
that punctate signals were a consequence of inadequate
tissue unmasking. Punctate signal patterns in a tissue
unmasked at one set of digestion conditions continued to
be detectable as punctate signal under more severe
unmasking conditions. Similarly diffuse signal patterns
did not appear as punctate when tissue was subject to less
severe unmasking conditions. Aneusomic chromosome
counts were also demonstrated following assay with cen-
tromeric probes (Figure 2D).
Comparisons of AEC and DAB on cervical tissues ISH
processed with DAKO wide-spectrum probe are shown in
Figures 3 (normal tissue), 5 (condylomatous lesion); 6
(CIN I); 8 (CIN II); 9 (CIN III); and 10 (squamous cell car-
cinoma). Figures 4 and 7 demonstrate normal cervix and
CIN I tissues hybridized with biotin-labeled pUC18 vec-
tor. Samples (Figures 34,5,6,7,8,9,10) were similarly proc-
essed apart from incubation with AEC or DAB. The
authors prefer AEC because:
1. Single-copy HPV-16 in SiHa cells is detectable using
AEC.
2. In the author's hands DAB generally tended to result in
background staining using the optimized protocol (Table
1) or the protocol supplied with the GenPoint kit. Back-
ground was found to be present even after 1 minute sub-
strate incubation. This staining has a 'grainy' appearance
that could be mistaken for punctate signals. Punctate-like
signals were found even with normal cervix hybridized
with HPV probe (Figure 4B) or lesion hybridized with
plasmid vector control probe (Figure 7B), and were com-
monly found congregated around nuclei circumferences
and also in cytoplasm (Figures
3B,4B,5B,6B,7B,8B,9B,10B).
3. AEC did not result in this type of staining. Leaving spec-
imens in AEC for up to 20 minutes only tended to result
in a pinkish blush to tissues and not the 'grainy' back-
ground obtained with DAB. Therefore it was easy to inter-
pret signals obtained using AEC as genuine HPV-related
correlates whereas with DAB, diffuse signals were easy to
interpret, but the interpretation of punctate signals was
generally open to question. Occasionally non-specific
staining was noted with AEC at the surperficial layers of
normal epithelium demonstrating parakeratosis.
Metaphase Spreads
SiHa Metaphase Chromosome Spread Preparation
Cells were split, media changed and 0.1µg/ml colcemid
added, 48 h, 24 h and 4–6 h prior to chromosome prepa-
ration respectively. After trypsinization cells were centri-
fuged at 400 g for 5 min, swollen in 75 mM KCl for 10
min at 37°C, re-centrifuged and fixed in methanol:acetic
acid (3:1) at 4°C, before dropping cells onto slides.BMC Clinical Pathology 2003, 3 http://www.biomedcentral.com/1472-6890/3/2
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Punctate Signals Figure 1
Punctate Signals. A. CaSki cells tissue section (6µm) demonstrating HPV-16 DNA integration at multiple sites. B. HeLa cells 
tissue section (6µm) demonstrating HPV-18 DNA integration at multiple sites. C. SiHa cell section (supplied by DAKO) dem-
onstrating HPV-16 DNA integration at a single site. D. Section (6µm) of an HPV-16 positive FFPE cervical squamous cell carci-
noma demonstrating punctate signals (arrows) indicative of integrated DNA. E. & F. Metaphase spreads prepared from SiHa 
cells demonstrating hybridization signal consistent with integration of HPV 16 at chromosome 13q21-31. Scale Bar: 10µm 
Note: Images were digitally captured using an Olympus BX50 research microscope fitted with an Optronics digital color cam-
era interfaced to a PC and operated using Universal Imaging MetaMorph software. Using the 'Exposure', 'White Balance' and 
'Red Green Blue Snap' default settings, the brick-red color of the AEC stain tended to be represented with a browner color. In 
addition there has been some loss of detail in the conversion of Figures (up to 35 megabytes in size) to pdf files ~250 kilobytes 
in size.
E.
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Hybridization
Slides of metaphase spreads were treated with 2% parafor-
maldehyde/PBS then rinsed with 0.2% glycine / PBS, PBS
and water then air-dried. Hybridization, wash and detec-
tion conditions were then applied as above except that
chromosomes were denatured by placing slides directly
onto a heating block set at 75°C for 7 min. HPV 16 signal
was not detected by staining with AEC or DAB. Detection
conditions were modified to enable fluorescent assay,
which successfully revealed integrated signal.
Following application of primary streptavidin-peroxidase
(1:300) and biotinyl-tyramide, streptavidin-FITC (Sigma
S3762) was applied at a final concentration of 0.0125 mg/
ml diluted in PBS/0.05% Tween 20 and incubated at
room temperature with the chromosome spreads for 30
minutes. After staining with DAPI, chromosomes were
visualized by fluorescence microscopy.
HPV 16 has been shown to be integrated at 13q21-q31 by
in situ hybridization analysis with 3 H-labeled probe and
chromosome identification by Geimsa staining [10] and
by detection of biotin-labeled HPV probe detected with
avidin-FITC, which enabled detection of integrated HPV
in metaphase spreads as a 'pin-prick' signal [11]. The SiHa
HPV Diffuse and Punctate Signals; Centromeric Probe Signals Figure 2
HPV Diffuse and Punctate Signals; Centromeric Probe Signals. A. HPV 51 sequences detected in a CIN1 lesion (6µm 
section). Diffuse signals only (brown arrows) were detected. Signal was absent from basal/parabasal layers suggesting low-copy 
number episomal HPV DNA may be undetectable by the assay. B. A CIN3 lesion (6µm section) positive for HPV16. Punctate 
signals (black arrows) were detected throughout the thickness of the epithelium and diffuse ones were also common, more so 
in superficial layers. C. An HPV 18 positive CIN2 lesion (6µm section) demonstrating only punctate signals. [The epithelium 
became dissociated from stromal tissues during tissue processing]. D. Section (6µm) of a FFPE carcinoma (see Figure 1D.) 
demonstrating chromosome 17 aneusomy following hybridization with a centromeric probe (D17Z1). Scale Bar: 10µm
' ' ' '
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Normal Cervix Hybridized with HPV Probe Figure 3
Normal Cervix Hybridized with HPV Probe. A. Normal cervix hybridized with DAKO wide spectrum probe and devel-
oped with AEC substrate (applied for 10 minutes) results in a clean background. B. A section from the same normal cervix 
treated with the same protocol as A. but using DAB (applied for 3 minutes) as substrate. There is generalized brown staining 
of epithelial cytoplasm and a tendency for 'punctate-like' signal to 'aggregate' around nuclei circumferences. There are occa-
sional 'punctate-like' signals within nuclei and also associated with cytoplasm. Taken together with the data in Figure 4., it is 
concluded the staining represents non-specific background. Scale Bar: 10µm
$ $ $ $
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cell line is aneusomic and has been found to contain 66 –
72 chromosomes, but to be diploid for the acrocentric
chromosome 13 [10].
Metaphase spreads hybridized with biotin-labeled HPV-
16 probe detected with biotinyl-tyramide and streptavi-
din-FITC, consistently demonstrated intense signal in the
central region of the long arm of an acrocentric chromo-
some (Figures 1E and 1F). By comparison with previous
studies [10,11] and because of the consistency of this
result, it is concluded that this signal represents the inte-
grated HPV 16 on chromosome 13. There is no commer-
cially available centromeric probe for chromosome 13 to
enable additional support for this interpretation.
Discussion
In this study the factors that enable consistent, sensitive
but background free in situ hybridization for DNA
sequences using biotinyl-tyramide reagent have been
investigated. Different protocols were compared and
assessed according to two criteria. Firstly whether the pro-
tocol was sufficiently sensitive to routinely detect single
copy (~8 kb) HPV-16 in SiHa cells/chromosome spreads,
and, secondly, whether the protocol routinely gave a clean
background on archival FFPE tissues. According to these
criteria a protocol has been optimized for routine use
(Table 1) that allows detection of the 1–2 copies of HPV
16 DNA integrated into the genome of SiHa cells utilizing
a chromogenic end-point. This protocol has been success-
fully applied to cell-line models (Figures 1A,1B,1C) and
Normal Cervix Hybridized with Biotin-Labeled pUC18 Figure 4
Normal Cervix Hybridized with Biotin-Labeled pUC18. A. Normal cervix hybridized with biotin-labeled pUC18 and 
developed with AEC substrate (applied for 10 minutes) results in a clean background. B. Normal cervix hybridized with biotin-
labeled pUC18 and developed with DAB substrate (applied for 3 minutes) results in brown-stained cytoplasm and punctate-like 
signals especially at nuclei circumferences and in the cytoplasm. Scale Bar: 10µm
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Cervical Condyloma Hybridized with HPV Probe Figure 5
Cervical Condyloma Hybridized with HPV Probe. A. A cervical condyloma hybridized with DAKO wide spectrum 
probe. Diffuse signals (brown arrows) are present in the upper layers and occasional punctate signal is detectable in basal/para-
basal layers. AEC was applied for 10 minutes. The authors have previously noted punctate signals in cervical condylomas in 
mid-/superficial layers [2], and Huang et al. [14] have also reported punctate signals deep in the basal layers of a laryngeal papil-
loma. B. A section of the same condyloma treated as A . except for use of DAB as substrate (applied for 3 minutes). Diffuse 
and punctate signals are evident however background staining that includes 'punctate' signals at nuclei circumferences and asso-
ciated with cytoplasm compromises data interpretation. Scale Bar: 10µm
$ $ $ $
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to examine HPV infections amongst archival FFPE cervical
carcinoma (Figure 1D) and CIN lesions (Figures
2A,2B,2C). Integration of HPV16 in metaphase chromo-
some spreads prepared from the SiHa cell-line has also
been demonstrated using a fluorescent reporter molecule
(Figures 1E and 1F).
The most important factors for high sensitivity were the
use a sodium citrate step followed by the use of pepsin/
HCl for tissue unmasking, the use of probes at a
concentration of > 0.5 ng/µl hybridization mix, and, the
concentration of primary streptavidin-peroxidase. That
HPV DNA integrated into metaphase chromosomes was
detectable by fluorescence but not chromogenic stains
indicates an additional order of sensitivity is possible by
combination of biotinyl-tyramide with reagents such as
FITC.
A sodium citrate tissue-unmasking step was also of key
importance for the elimination of background staining.
AEC was the chromogen of choice for clean background.
Certain probes were more "dirty" than others. Composi-
tion and pH of hybridization mix and post-hybridization
wash buffer pH were important in these instances.
The optimized protocol was applied to archival FFPE cer-
vical carcinomas and CIN lesions for the detection of HPV
DNA. "Punctate" signals were detected amongst carcino-
CIN I Lesion Hybridized with HPV Probe Figure 6
CIN I Lesion Hybridized with HPV Probe. A. A CIN I lesion hybridized with DAKO wide spectrum probe. Diffuse signals 
are evident in the superficial layers. AEC was applied for 10 minutes. B. A section from the same lesion treated with DAB for 
3 minutes. There are diffuse signals at the superficial layers. There are numerous fine punctate-like signals throughout the epi-
thelial thickness, however as before these are frequently found on the circumference of nuclei and associated with cytoplasm 
making their interpretation as genuine HPV-related hybridization signal unreliable. Scale Bar: 20µm
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CIN I Lesion Hybridized with Biotin-Labeled pUC18 Figure 7
CIN I Lesion Hybridized with Biotin-Labeled pUC18. A. A CIN I lesion (Figure 6.) hybridized with biotin-labeled 
pUC18 resulting in a background-free section. AEC was applied for 10 minutes. B. A CIN I lesion (Figure 6.) hybridized with 
biotin-labeled pUC18 resulting in punctate-like signals around cells and in the cytoplasm. DAB was applied for 3 minutes. This 
non-specific staining demonstrates that care is required when interpreting DAB signals, and illustrates the necessity to perform 
proper control assays when using tyramide reagents. Scale Bar: 20µm
% % % %
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CIN II Lesion Hybridized with HPV Probe Figure 8
CIN II Lesion Hybridized with HPV Probe. A. A CIN II lesion hybridized with DAKO wide-spectrum probe and incu-
bated with AEC for 10 minutes. Diffuse and punctate signals are evident (arrows). B. Tissue from the same lesion incubated 
with DAB for 3 minutes. Diffuse and puncate signals are evident but there are also numerous punctate-like signals not associ-
ated with cell nuclei that compromise interpretation. Scale Bar: 10µm
$ $ $ $
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CIN III Lesion Hybridized with HPV Probe Figure 9
CIN III Lesion Hybridized with HPV Probe. A. A CIN III lesion processed using AEC substrate (applied for 10 minutes). 
Punctate signals are prominent in the basal layers. Diffuse signal is also present. B. A section from the same lesion processed 
using DAB (applied for 1 minute). Diffuse and punctate signals are detectable. There is also considerable background staining. 
Note: A. and B. are both slightly over-digested as indicated by the weak hematoxylin staining and loss of tissue morphology. 
Tissue over-digestion generally resulted in increased background with DAB but with AEC background remained clean.Scale 
Bar: 10µm
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Carcinoma Hybridized with HPV Probe Figure 10
Carcinoma Hybridized with HPV Probe. A. HPV hybridization signals in a cervical squamous cell carcinoma demon-
strated with AEC (applied for 10 minutes). B. A section from the same carcinoma with hybridization signal demonstrated with 
DAB (applied for 3 minutes). A given signal is more intense with DAB than with AEC, however overall the information about 
the carcinoma that is gained with DAB is also obtained with AEC as a similar proportion of cells demonstrate 1 or 2 HPV sig-
nals after application of either substrate. Background is relatively clean with DAB on this sample. Scale Bar: 10µm
$ $ $ $
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mas and high-grade CIN lesions but were rare amongst
(non-conylomatous) CIN I lesions, which were character-
ized by "diffuse" signals occupying entire nuclei and
detectable in the mid/superficial layers. These
observations are consistent with earlier studies that a
punctate signal is representative of integration and a dif-
fuse signal of episomal HPV, and with the theory that
integration is an important factor in lesion progression
[2,12]. The data suggest the optimized method may be
useful in screening CIN lesions for integration. However,
further studies are required to confirm a punctate signal is
only representative of integration. The demonstration of
1–2 copies of integrated HPV DNA detected as punctate
signal begs the question as to why single/low-copy episo-
mal HPV is not also detectable as punctate signal. Initial
infection with HPV is understood to occur in the basal
layer of the epithelium, and productive replication is tied
to cell differentiation/maturation (Figure 2A.) [13]. HPV
was not detected by the assay in basal/parabasal cells of
(non-condylomatous) CIN I lesions (> 30 examined;
unless HPV-16 positive [2]) suggesting low-copy number
episomal HPV was not detectable and indicating a limit to
the sensitivity of the assay.
A possible explanation maybe that that ~8 kilo-base sin-
gle/low-copy episomal HPV sequences may be subject to
relatively more degradation and loss from tissues during
routine processing than HPV DNA that is physically inte-
grated into the human chromosome (~50 – 250 mega-
base pairs). Excessive degradation may affect retention of
DNA sequences during in situ hybridization assay as well
as hybridization efficiency. Additionally/alternatively, the
sensitivity of the assay on archival tissues may be less than
that on the SiHa cell-line model despite attempting
equivalent procedures through formalin-fixation and rou-
tine paraffin embedding. If this is the case, then punctate
signal detected in carcinomas and high-grade CIN lesions
may only represent integration of multiple copies of HPV
at sites within the genome, and low-copy episomal (or
integrated) DNA may remain sub-threshold on archival
FFPE samples. Episomal HPV can also occur in the form
of concatamers comprising multiple copies of the HPV
genome compounded into 'super-molecules'. It can be
speculated that these forms could also give rise to punc-
tate signals.
Centromeric probe signal was readily demonstrable using
biotinyl-tyramide based in situ hybridization (Figure 2D).
Currently numerical chromosome count is generally
determined by hybridization with directly labeled fluores-
cent probes. This has the advantages of allowing simulta-
neous assay of two or more differently labeled probes and
detection directly after post-hybridization washes. The
disadvantage is the requirement for specialized micros-
copy, visualization of tissue specimens through multiple
filters, multiple image capture, and the relatively short
half-life during which signal is visible. Biotinyl-tyramide
assay has the disadvantage of requiring several incuba-
tions to detect biotin label. It has the advantages of allow-
ing hematoxylin counterstaining that allows easier
determination of cell/tissue morphology, visualization by
bright field microscopy, and signal that is available for
counting more than one year after test application (slides
have been kept in the dark). Unequivocal signal was also
demonstrated (to the authors' knowledge for first time by
a tyramide based assay) of the 1–2 copies of HPV16 inte-
grated at chromosome 13q21-31 (Figure 1E and 1F) on
metaphase spreads prepared from SiHa cells.
There are many variables associated with tyramide-ISH. In
this study a number of these have been systematically
examined and a sensitive background-free assay has been
demonstrated. In this study biotin-labeled probes and
biotinylated-tyramide were utilized. Background may also
be reduced by using digoxigenin-labeled probe and anti-
digoxigenin antibody conjugated with horseradish perox-
idase before the amplification step of biotinyl-tyramide
(Dr. Chao-Cheng Huang, personal communication). Pos-
sibly oligonucleotide probes may also give less back-
ground than full-length sequences. Non-biotin-based-
tyramide reagents, including fluorescent reagents are
available from PerkinElmer Life Sciences and from DAKO.
These reagents (used in conjunction with non-biotin-
labeled probes) may be particularly beneficial for applica-
tions on tissues where endogenous biotin is problematic.
An additional level of sensitivity may be possible on
tissues using fluorescene given the finding that HPV inte-
grated on chromosome spreads could be demonstrated
with FITC but not AEC or DAB.
Conclusions
A biotinyl-tyramide-based in situ hybridization protocol
has been optimized that allows sensitive detection of
DNA sequences in FFPE tissues and metaphase spreads.
The protocol is especially robust with respect to absence of
background staining that can limit assay interpretation. As
such the protocol may have clinical utility in the survey of
routine cervical samples for HPV 'punctate' signals that
are associated with high-grade lesions. Additionally the
method can be used to detect numerical chromosome
aberrations in archival pathology samples and so repre-
sents an alternative to the use of FISH assays that require
specialized microscopy.
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